21 /100
LOW RISK
Score updated Jul 13, 2026

ATOM — Atomera Incorporated Dilution Risk Tracker

Track ATOM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATOM — Get alerts when the score changes →

As of July 13, 2026, Atomera Incorporated (ATOM) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Atomera Incorporated has a market capitalization of $386.39M, 38.72M shares outstanding, 10 institutional holders tracked. Key dilution vectors include ATM program capacity of $25.00M, 196.5K outstanding warrants, approximately 28 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
31
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $25M remaining capacity
🔔 Track ATOM — Get forecast alerts →

💹 Market Data

Market Cap$386.39M
Shares Outstanding38.72M
Float37.43M
Cash$41.09M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 7.44M shares
#1 Blackrock Inc. 1.97M shares
#2 Vanguard Group Inc 1.65M shares
#3 Geode Capital Management, LLC 741.0K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest5.86M
Days to Cover5.5
% of Float15.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2020
4 INSIDER TRANSACTION Mar 13, 2026
4 INSIDER TRANSACTION Mar 13, 2026
4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ATOM Shareholders

Atomera Incorporated (ATOM) has a DilutionScore of 21/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

ATOM has an active ATM (at-the-market) program with $25.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. DilutionWatch tracks 196,502 outstanding warrants for ATOM. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for ATOM in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ATOM alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work → Warrants Explained →
Track ATOM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATOM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ATOM
📊 ATOM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ATOM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.